BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20384750)

  • 1. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
    [No Abstract]   [Full Text] [Related]  

  • 3. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
    Ochoa BE; Sah D; Wang G; Stamper R; Price VH
    J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

  • 5. Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.
    Smith S; Fagien S; Whitcup SM; Ledon F; Somogyi C; Weng E; Beddingfield FC
    J Am Acad Dermatol; 2012 May; 66(5):801-6. PubMed ID: 21899919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
    Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
    Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.
    Tauchi M; Fuchs TA; Kellenberger AJ; Woodward DF; Paus R; Lütjen-Drecoll E
    Br J Dermatol; 2010 Jun; 162(6):1186-97. PubMed ID: 20346040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.
    Yoelin S; Walt JG; Earl M
    Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: From serendipity to pilot study and then pivotal trial: bimatoprost topical for eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 May; 36(5):650-1. PubMed ID: 20384740
    [No Abstract]   [Full Text] [Related]  

  • 10. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latisse: empirical discovery yields treatment for sparse eyelashes.
    Woodson SA
    Nurs Womens Health; 2009 Jun; 13(3):243-8. PubMed ID: 19523139
    [No Abstract]   [Full Text] [Related]  

  • 12. Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement.
    Woodward JA; Haggerty CJ; Stinnett SS; Williams ZY
    J Cosmet Dermatol; 2010 Jun; 9(2):96-102. PubMed ID: 20618554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced eyelashes: prescription and over-the-counter options.
    Jones D
    Aesthetic Plast Surg; 2011 Feb; 35(1):116-21. PubMed ID: 20730536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases.
    Vergilis-Kalner IJ
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
    Harii K; Arase S; Tsuboi R; Weng E; Daniels S; VanDenburgh A
    Aesthetic Plast Surg; 2014 Apr; 38(2):451-60. PubMed ID: 24643895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latisse (bimatoprost) for enhancement of eyelashes.
    Flaharty PM; Flaharty KK; Gorman L
    Insight; 2014; 39(3):24-6. PubMed ID: 25195339
    [No Abstract]   [Full Text] [Related]  

  • 17. Company profits from side effects of glaucoma treatment.
    Banaszek A
    CMAJ; 2011 Oct; 183(14):E1058. PubMed ID: 21876012
    [No Abstract]   [Full Text] [Related]  

  • 18. Eyelash growth: a beneficial side effect of prostaglandin analogues.
    Bikowski J; Lau EG; Jacob SE
    Cutis; 2010 Apr; 85(4):187-8. PubMed ID: 20486457
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical management of trichotillomania with bimatoprost.
    Peabody T; Reitz S; Smith J; Teti B
    Optom Vis Sci; 2013 Jun; 90(6):e167-71. PubMed ID: 23645373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
    Fagien S
    Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.